Replies to post #35883 on RespireRx Pharmaceuticals Inc (RSPI)

[DFRAI]

Its Bush's fault, he made me buy it.

[meixatech]

Many BPs are either closing down their research facilities or substantially reducing their size. So, just where are the new drugs going to come from that require the BPs to surive? Small or micro cap biotech such as Cortex is really the only answer. Unlike most of you, I put much more weight on the enormous number of published papers and the combined early clinical trial results of ampakines, as an indicator of the extraordinary success possible by Cortex. Many of you are too engrained in recent history of small cap biotechs.

[gfp927z]

Enemem, >>> Raise cash to do what? <<<


To buy time to get to an ADHD (or other) deal, similar to how the Samyang financing bought time to get to the Biovail deal. You'd think ADHD would be an easier sell than RD, but with pharmas cutting back on their R+D (especially CNS) it still might take a while. Add in the other potential factors like Schizo/Depression, SA/RD, high impacts, etc, and a deal could take some time.

So I'm still figuring on an interim financing by ~ May and then some kind of deal later in the year that enables ADHD to go forward. Or perhaps Varney has tired of the game and will decide to fold the tent and move on like Tran did. What happens this year might surprise everyone.